Transforming Egypt's Healthcare System Project (WB-P167000)

  • Egypt
Where the impacts of the investment may be experienced.
Financial Institutions
  • World Bank (WB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Bank Risk Rating
Risk rating varies among banks and may refer only to the particular investment and not to the risk for the project as a whole. Projects marked 'U' have an 'Unknown' risk rating at the time of disclosure.
Voting Date
Jun 27, 2018
The estimate day the bank will vote on a proposed investment. The decision dates may change, so review updated project documents or contact the EWS team.
Government of Egypt
The holder of the loan, grant, or other investment.
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, etc.
Investment Amount (USD)
$ 530.00 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please review updated project documents for more information.
Project Cost (USD)
$ 992.50 million
Value listed on project documents at time of disclosure. If necessary, converted to USD$. Please see updated project documentation for more information.
Primary Source

Original disclosure @ WB website

Updated in EWS Jul 10, 2018

Disclosed by Bank Mar 26, 2018

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description

The project design builds upon the successful outcomes of Healthcare Quality Improvement Project (HQIP) in improving the quality of primary health cares (PHCs), supporting a hospital accreditation pilot, and screening and treatment of Hep C. As under HQIP, the proposed project will follow a decentralized implementation approach and will expand accreditation of PHCs and hospitals, screen and treat Hep C. Capitalizing on the proposed Hep C interventions, the project will screen for the risk factors of the diseases that are the leading causes of deaths (e.g. diabetes and hypertension). Furthermore, the project proposes transformational support to key services that underpin the health system, including the pharmaceutical supply chain and blood banks.

The project has the following four components:

  1. Strengthen community and primary health care services. This component will support the following:
    1. Accreditation of PHCs.
    2. Screening for Hep C and risk factors for high burden diseases.
    3. Strengthen community health worker (CHW) program.
  2. Strengthening secondary level care. This component will strengthen the integration of services through enhancing procedures, logistics and operations that would empower hospitals to provide comprehensive quality services to the population residing in their catchment areas. The component will also support the roll-out of a pharmaceutical supply chain system and enhance activities aiming at maintaining safe blood supplies. This component will support the following:
    1. Accreditation of hospitals. 
    2. Improve the pharmaceutical supply chain and the blood bank network.
    3. (iii) Treatment of Hep C. This will support the provision of treatment of patients who screened positive for Hep C, as
      well as efforts to ensure that patients who initiate treatment are reported as being cured based upon a posttreatment cure confirmation test.
  3. Institutional Capacity Building and Project Management: This component will support the following:
    1. Project Management and Monitoring and Evaluation. This will include support for the Project Management Unit (PMU), training for MOHP staff, and contracting External Technical Advisors (ETA), Financial auditors and ThirdParty verification.
    2. Institutional Strengthening to provide selected technical assistance to strengthen the institutional capacity of key relevant public sector agencies for the roll-out of the Comprehensive Health Insurance System.
  4. Contingency Emergency and Response Component: This component would allow for a quick realignment of resources within the total project financing envelope to boost the country’s response in the event of a national health emergency
Investment Description
  • World Bank (WB)
Contact Information

Ministry of Investment and International Cooperation
Tarek Abdel-Sattar
Program Manager- Financial, Social and Transport Sectors

Implementing Agency:
Ministry of Health and Population
Yasser Omar
Head of Loans and Grants department 


The World Bank Inspection Panel is the independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by a World Bank-financed project. If you submit a complaint to the Inspection Panel, they may investigate to assess whether the World Bank is following its own policies and procedures for preventing harm to people or the environment. You can contact the Inspection Panel or submit a complaint by emailing You can learn more about the Inspection Panel and how to file a complaint at: